After years of writing and editing, the first physical copy of CHINA CURE: The Rise of a Biotech, AI Medicine and Global Health Superpower (both hardback and e-book) has finally arrived!
It really is a special feeling to hold my first book in print, and with publication coming up on 31 October, I’m looking forward to getting out, meeting readers and discussing the ideas in the book. You can already pre-order it online or request it through bookshops in the UK and US.
I introduced the book here on ChinaHealthPulse back in July, sharing why I wrote it, some of the personal stories behind it, and the questions it explores about China’s extraordinary transformations across healthcare, biotechnology and AI medicine.
At a time when China is making such remarkable advances in health innovation, while relations between countries are becoming increasingly complicated, understanding how this transformation happened and what it means for healthcare around the world feels particularly important.
I’ve already had some fascinating conversations about these questions, and wanted to share a few of them below.
There are plenty more to come! I’ll be speaking at events in London, Oxford and online over the next few weeks, with further dates planned for November, including in the US. I would love to meet some of you, hear your perspectives and find out what you make of the book!
Upcoming events
Friday 16 October | 2–3pm BST | Online
China-Britain Business Council: The Evolution of the Chinese Pharmaceutical Industry
In conversation with Elinor Greenhouse.
Monday 19 October | 10.30–11.30am | London
Lau China Institute, King’s College London
In conversation with Professor Kerry Brown, who very kindly wrote the foreword to the book.
Books will be available to purchase.
Wednesday 21 October | 12–1pm | Oxford
University of Oxford, Oxford China Centre
with Professor Todd Hall.
Monday 2nd November | 7–8.30pm | London
London Business School.
Registration details to follow, books will be optionally included in the ticket.
More events are being planned for November, including in London and across the US East Coast. I'll continue to share details as they're confirmed.
Podcasts, webinars and conversations
Over the past few months, I’ve been discussing different aspects of China’s changing role in medicine, technology and global health with journalists, researchers and fellow China watchers. Here are some recent conversations and pieces.
Video: podcasts and webinars
Sinica Podcast: From Barefoot Doctors to Biologics — A conversation with Kaiser Kuo about my book and China’s healthcare transformation, its historical roots and the country’s emergence as a global biotechnology power.
Prof G / China Decode with Scott Galloway — I joined Alice Han and James Kynge to discuss the economic and national security implications of China’s rise in biotech.
National Committee on U.S.-China Relations: U.S.-China Clinical Research: Speed, Evidence, and Global Competitiveness — A conversation with Dr Amy Abernethy, former Principal Deputy Commissioner of the US FDA, about why clinical trials can move faster in China, the trade-offs between speed and scientific rigour and what the US and China can learn from each other.
Asia Scotland Institute: China’s Rise in Biotechnology, Digital Health and AI Medicine — I joined Hilda Fuentes, moderated by Jonathan Di Rollo, to discuss China’s rapid adoption of AI in healthcare, the opportunities and risks for patients and clinicians, and what healthcare systems in Peru, Latin America and beyond can learn from China’s experience.
Articles, interviews and media coverage
Rest of World: China is excelling in health tech. That’s good news for the world — An interview about China’s biotechnology and digital health advances, and their growing international significance.
Nature: China is changing the shape of global health. The terms are still up for negotiation — On China’s expanding health partnerships and how other countries can benefit from new opportunities while preserving local capacity and sovereignty.
Journal of Medical Internet Research: When the Algorithm Starts Seeing the Patient First — On China’s rapid adoption of AI in healthcare and what this means for doctors, patients and health systems elsewhere.
South China Morning Post: Rising US scrutiny on clinical trials could threaten China’s biotech advantage, by Xinmei Shen — On China’s advantages in faster, lower-cost clinical trials, and how growing US regulatory and political scrutiny could affect international biotech collaboration.
Nature: China’s fast-track clinical trials are in the spotlight after child deaths, by Xiaoying You — On China’s investigator-initiated trials (IITs), the balance between speed, innovation and patient safety, and the growing importance of regulatory oversight as the country’s biotech sector advances.
Thank you to everyone who has followed and supported the journey so far. I'm very excited to finally share the book with you, and hope to see some of you at an event over the coming weeks!
I’ll keep this post updated with new events, interviews and articles as they come out.
For media enquiries, book reviews, podcasts or speaking invitations, please feel free to get in touch.